Why It Matters
End Kratom Addiction hired Bob Good LLC in a Aug. 3 filing, with a focused lobbying effort on alcohol and drug abuse issues. Regulation on kratom, a unregulated supplement, has become a flashpoint between public health advocates and industry players.
The filing reports no lobbying income for the registration period. Bob Good, the sole lobbyist listed, has no prior government experience and no congressional staff experience on record. Bob Good LLC has one active client, generating $10,000 in revenue in the past quarter.
Broader Context
The Food and Drug Administration (FDA) issued a formal recommendation in July 2025 that concentrated 7-hydroxymitragynine (7-OH), a powerful opioid compound derived from kratom, be scheduled as Schedule I. As of July 2026, kratom is banned in nine states: Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Tennessee, Vermont, and Wisconsin.
Industry groups representing kratom producers have been building out their lobbying operations in response to federal regulatory pressure.
"Stop Gas Station Heroin advocates for stronger regulation of dangerous concentrated synthetic 7-hydroxymitragynine products," a spokesperson for Marathon Strategies on behalf of Stop Gas Station Heroin told Legis1. "Its work is focused on protecting consumers and establishing a clear regulatory distinction between these products and unenhanced natural kratom leaf."
Access the Legis1 platform for comprehensive political news, data, and insights.
Spot something wrong? Report an issue with this article